Dongfang Baitai is a biomedical research and development company, focusing on new preventive biomedical products, using high-throughput innovative antibody screening, therapeutic vaccine development, antibody drug (ADC) coupling and other technical platforms to provide users with Exendin-4 fusion Protein, anti-TNF-α fully human antibody, anti-VEGF humanized antibody, antibody toxin conjugated drug ADC and other products, used in lung cancer, colorectal cancer, kidney cancer, breast cancer, glioblastoma and macular degeneration treatment of other diseases.